Entrada Therapeutics
TRDA
TRDA
103 hedge funds and large institutions have $560M invested in Entrada Therapeutics in 2024 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 24 reducing their positions, and 14 closing their positions.
Holders
103
Holders Change
+6
Holders Change %
+6.19%
% of All Funds
1.37%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
20
Increased
43
Reduced
24
Closed
14
Calls
$717K
Puts
$103K
Net Calls
+$614K
Net Calls Change
+$325K
Top Buyers
1 |
MC
1
Merck & Co
Kenilworth,
New Jersey
|
$30.1M |
2 |
2
Janus Henderson Group
London,
United Kingdom
|
$36M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$25.3M |
4 |
4
Goldman Sachs
New York
|
$4.93M |
5 |
5
BlackRock
New York
|
$34.1M |